MAPT and Alzheimer disease: Overall, these findings suggest that HFHS-driven metabolic stress affects brain function and behavior through specific cellular programs distinct from amyloid or tau pathology, and identifies new targets that link diet-induced metabolic stress to cognitive decline in AD.